Connect Sign In
Dehydroepiandrosterone Sulfate, Serum
Ordering Recommendation
Indicator of adrenal androgen production. Aids in the investigation of virilizing endocrinopathies in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.
New York DOH Approval Status
Specimen Required
Serum separator tube or plasma separator tube. Also acceptable: Green ( lithium heparin), lavender (K2 or K3 EDTA), or pink (K2EDTA).
Allow specimen to clot completely at room temperature. Separate serum or plasma from cells ASAP or within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)
Frozen.
Hemolyzed specimens.
After separation from cells: Ambient: 5 days; Refrigerated: 14 days; Frozen: 12 months
Methodology
Quantitative Electrochemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours
Reference Interval
| Age |
Male |
Female |
|---|---|---|
| 0-6 days 7-30 days 1-5 months 6-35 months 3-6 years 7-9 years 10-14 years 15-19 years 20-24 years 25-34 years 35-44 years 45-54 years 55-64 years 65-74 years 75 years and older |
108-607 µg/dL 32-431 µg/dL 3-124µg/dL 0-33 µg/dL 0-44 µg/dL 5-115 µg/dL 22-332 µg/dL 88-483 µg/dL 211-492 µg/dL 160-449 µg/dL 89-427 µg/dL 44-331µg/dL 52-295 µg/dL 34-249 µg/dL 16-123 µg/dL |
108-607 µg/dL 32-431 µg/dL 3-124 µg/dL 0-29 µg/dL 0-47 µg/dL 5-94 µg/dL 22-255 µg/dL 63-373 µg/dL 148-407 µg/dL 99-340µg/dL 61-337 µg/dL 35-256 µg/dL 19-205 µg/dL 9-246 µg/dL 12-154 µg/dL |
| Tanner Stage I Tanner Stage II Tanner Stage III Tanner Stage IV & V |
7-209 µg/dL 28-260 µg/dL 39-390 µg/dL 81-488 µg/dL |
7-126 µg/dL 13-241 µg/dL 32-446 µg/dL 65-371 µg/dL |
Interpretive Data
FDA
Note
Hotline History
CPT Codes
82627
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0070040 | DHEAS | 2191-5 |
Aliases
- Dehydroepiandrosterone Sulfate, Serum
- DHEA S04
- DHEA Sulfate
- DHEA-S
- DHEA-SO4
- DHEAS, Serum
